bernard_poussot_roche

Roche adds two to its board

pharmafile | December 18, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Bernard Poussot, Richard Lift, Roche, Sanofi 

Roche intends to grow at its March annual general meeting via the election of Bernard Poussot and Richard Lift who are to join the Swiss firm’s board.

Poussot (pictured) is the former chief executive of Wyeth, and keen observers would now note that this news means any chance of him going to the Sanofi top job is now off the cards. 

After beginning his career in France Poussot led Wyeth until its acquisition by Pfizer in 2009. Some in the industry considered him a choice fit for Sanofi as it seeks a replacement chief executive, following the French company’s decision to remove Christopher Viehbacher in October.  

Advertisement

Roche chairman Christoph Franz says: “I am delighted that we are able to propose two outstanding individuals to be elected as new members of the board who will bring significant experience from their careers in the pharmaceutical industry and in biomedical research, respectively.”

Related Content

Excellence in Healthcare Partnership Awards – A Collaborative Working Project Between Sanofi and The University Hospital Birmingham Severe Asthma Team

Launched in February 2026 by PMGroup Worldwide Ltd and Visions4Health, the Excellence in Healthcare Partnerships …

Roche secures CE Mark for automated latent tuberculosis blood test

Roche has received CE Mark approval for its Elecsys IGRA TB test, an automated blood …

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance …

The Gateway to Local Adoption Series

Latest content